Effect of oxidative stress on the production of recombinant human interferon-gamma in Escherichia coli. 2005

Jafar Mohammadian-Mosaabadi, and Hossein Naderi-Manesh, and Nader Maghsoudi, and Rasoul Khalilzadeh, and Seyd Abbas Shojaosadati, and Marzieh Ebrahimi
Biochemistry Group, Department of Biology, Faculty of Science, Tarbiat Modarres University, Tehran, PO Box 14155-4838, Iran.

To reduce the degradation pathway of rhIFN-gamma (recombinant human interferon-gamma), the susceptibility against oxidative stress during fermentation in Escherichia coli cells and in purification process were investigated. Fermentations of recombinant E. coli were performed at 5, 30 and 60% DO (dissolved oxygen) concentrations. The expressed rhIFN-gamma is purified in three-step chromatography processes with 99.9% purity under reducing and non-reducing conditions. Recombinant IFN-gamma production, carbonyl and dimeric contents and antiviral-specific activity of purified protein were monitored. The increase in carbonyl content was taken to be an indicator of protein oxidation. DO concentration did not show any noticeable effect on rhIFN-gamma production. During fermentation, the carbonyl-group content showed no significant increase at 5 and 30% DO but a 10-fold increase at 60% DO concentration was observed. The antiviral-specific activity of purified rhIFN-gamma was decreased 35 and 69% at 30 and 60% DO concentrations respectively. After the purification process, under non-reducing conditions, the activity of purified protein decreased to 30% of its original value. The degree of dimeric forms of protein was found to depend on the O2 concentration during fermentation and purification.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015202 Protein Engineering Procedures by which protein structure and function are changed or created in vitro by altering existing or synthesizing new structural genes that direct the synthesis of proteins with sought-after properties. Such procedures may include the design of MOLECULAR MODELS of proteins using COMPUTER GRAPHICS or other molecular modeling techniques; site-specific mutagenesis (MUTAGENESIS, SITE-SPECIFIC) of existing genes; and DIRECTED MOLECULAR EVOLUTION techniques to create new genes. Genetic Engineering of Proteins,Genetic Engineering, Protein,Proteins, Genetic Engineering,Engineering, Protein,Engineering, Protein Genetic,Protein Genetic Engineering
D018384 Oxidative Stress A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi). Anti-oxidative Stress,Antioxidative Stress,DNA Oxidative Damage,Nitro-Oxidative Stress,Oxidative Cleavage,Oxidative DNA Damage,Oxidative Damage,Oxidative Injury,Oxidative Nitrative Stress,Oxidative Stress Injury,Oxidative and Nitrosative Stress,Stress, Oxidative,Anti oxidative Stress,Anti-oxidative Stresses,Antioxidative Stresses,Cleavage, Oxidative,DNA Damage, Oxidative,DNA Oxidative Damages,Damage, DNA Oxidative,Damage, Oxidative,Damage, Oxidative DNA,Injury, Oxidative,Injury, Oxidative Stress,Nitrative Stress, Oxidative,Nitro Oxidative Stress,Nitro-Oxidative Stresses,Oxidative Cleavages,Oxidative DNA Damages,Oxidative Damage, DNA,Oxidative Damages,Oxidative Injuries,Oxidative Nitrative Stresses,Oxidative Stress Injuries,Oxidative Stresses,Stress Injury, Oxidative,Stress, Anti-oxidative,Stress, Antioxidative,Stress, Nitro-Oxidative,Stress, Oxidative Nitrative,Stresses, Nitro-Oxidative
D018929 Cell Culture Techniques Methods for maintaining or growing CELLS in vitro. Cell Culture,Cell Culture Technique,Cell Cultures,Culture Technique, Cell,Culture Techniques, Cell
D019149 Bioreactors Tools or devices for generating products using the synthetic or chemical conversion capacity of a biological system. They can be classical fermentors, cell culture perfusion systems, or enzyme bioreactors. For production of proteins or enzymes, recombinant microorganisms such as bacteria, mammalian cells, or insect or plant cells are usually chosen. Fermentors,Bioreactor,Fermentor

Related Publications

Jafar Mohammadian-Mosaabadi, and Hossein Naderi-Manesh, and Nader Maghsoudi, and Rasoul Khalilzadeh, and Seyd Abbas Shojaosadati, and Marzieh Ebrahimi
February 2004, Journal of industrial microbiology & biotechnology,
Jafar Mohammadian-Mosaabadi, and Hossein Naderi-Manesh, and Nader Maghsoudi, and Rasoul Khalilzadeh, and Seyd Abbas Shojaosadati, and Marzieh Ebrahimi
April 1993, Journal of interferon research,
Jafar Mohammadian-Mosaabadi, and Hossein Naderi-Manesh, and Nader Maghsoudi, and Rasoul Khalilzadeh, and Seyd Abbas Shojaosadati, and Marzieh Ebrahimi
July 1990, Applied microbiology and biotechnology,
Jafar Mohammadian-Mosaabadi, and Hossein Naderi-Manesh, and Nader Maghsoudi, and Rasoul Khalilzadeh, and Seyd Abbas Shojaosadati, and Marzieh Ebrahimi
October 2018, Enzyme and microbial technology,
Jafar Mohammadian-Mosaabadi, and Hossein Naderi-Manesh, and Nader Maghsoudi, and Rasoul Khalilzadeh, and Seyd Abbas Shojaosadati, and Marzieh Ebrahimi
April 2001, Infection and immunity,
Jafar Mohammadian-Mosaabadi, and Hossein Naderi-Manesh, and Nader Maghsoudi, and Rasoul Khalilzadeh, and Seyd Abbas Shojaosadati, and Marzieh Ebrahimi
October 1990, Arzneimittel-Forschung,
Jafar Mohammadian-Mosaabadi, and Hossein Naderi-Manesh, and Nader Maghsoudi, and Rasoul Khalilzadeh, and Seyd Abbas Shojaosadati, and Marzieh Ebrahimi
April 2010, Applied biochemistry and biotechnology,
Jafar Mohammadian-Mosaabadi, and Hossein Naderi-Manesh, and Nader Maghsoudi, and Rasoul Khalilzadeh, and Seyd Abbas Shojaosadati, and Marzieh Ebrahimi
August 1987, Biochemistry,
Jafar Mohammadian-Mosaabadi, and Hossein Naderi-Manesh, and Nader Maghsoudi, and Rasoul Khalilzadeh, and Seyd Abbas Shojaosadati, and Marzieh Ebrahimi
July 1985, Clinical immunology and immunopathology,
Jafar Mohammadian-Mosaabadi, and Hossein Naderi-Manesh, and Nader Maghsoudi, and Rasoul Khalilzadeh, and Seyd Abbas Shojaosadati, and Marzieh Ebrahimi
July 2010, Comparative immunology, microbiology and infectious diseases,
Copied contents to your clipboard!